Synthesis and bioactivity evaluation of n-arylsulfonylindole analogs bearing a rhodanine moiety as antibacterial agents

Molecules

Volumn 22, Issue 6, 2017, Pages

  Song, Ming Xia ^a   Li, Song Hui ^a   Peng, Jiao Yang ^a   Guo, Ting Ting ^a   Xu, Wen Hui ^a   Xiong, Shao Feng ^a   Deng, Xian Qing ^a  

^a JINGGANGSHAN UNIVERSITY   (China)

Author keywords

Antibacterial activity; N arylsulfonylindole; Propanoic acid; Rhodanine

Indexed keywords

ANTIINFECTIVE AGENT; ARYLSULFONIC ACID DERIVATIVE; INDOLE; INDOLE DERIVATIVE; RHODANINE;

CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI; HUMAN; MICROBIAL SENSITIVITY TEST; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ARYLSULFONIC ACIDS; ESCHERICHIA COLI; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS; RHODANINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85021110798     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22060970     Document Type: Article

References (31)

1. Livermore, D.M. Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 2009, 64 (Suppl. 1), i29–i36. [CrossRef] [PubMed]
2. Bi, Y.; Liu, X.X.; Zhang, H.Y.; Yang, X.; Liu, Z.Y.; Lu, J.; Lewis, P.J.; Wang, C.Z.; Xu, J.Y.; Meng, Q.G.; et al. Synthesis and Antibacterial Evaluation of Novel 3-Substituted Ocotillol-Type Derivatives as Leads. Molecules 2017, 22, 590. [CrossRef] [PubMed]
3. Carrel, M.; Perencevich, E.N.; David, M.Z. USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013. Emerg. Infect. Dis. 2015, 21, 1973–1980. [CrossRef] [PubMed]
4. Hvistendahl, M. Public health. China takes aim at rampant antibiotic resistance. Science 2012, 336, 795. [CrossRef] [PubMed]
5. Yezli, S.; Li, H. Antibiotic resistance amongst healthcare-associated pathogens in China. Int. J. Antimicrob. Agents 2012, 40, 389–397. [CrossRef] [PubMed]
6. Azeredo da Silveira, S.; Perez, A. Liposomes as novel anti-infectives targeting bacterial virulence factors? Expert. Rev. Anti-Infect. Ther. 2015, 13, 531–533. [CrossRef] [PubMed]
7. Cascioferro, S.; Cusimano, M.G.; Schillaci, D. Antiadhesion agents against Gram-positive pathogens. Future Microbiol. 2014, 9, 1209–1220. [CrossRef] [PubMed]
8. Tay, S.B.; Yew, W.S. Development of quorum-based anti-virulence therapeutics targeting Gram negative bacterial pathogens. Int. J. Mol. Sci. 2013, 14, 16570–16599. [CrossRef] [PubMed]
9. Rademacher, J.; Welte, T. New antibiotics - standstill or progress. Med. Klin. Intensivmed. Notfmed. 2017, 112, 206–213. [CrossRef] [PubMed]
10. Boucher, H.W.; Talbot, G.H.; Benjamin, D.K.; Bradley, J.; Guidos, R.J.; Jones, R.N.; Murray, B.E.; Bonomo, R.A.; Gilbert, D. Infectious Diseases Society of America. 10 x '20 Progress–development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin. Infect. Dis. 2013, 56, 1685–1694. [CrossRef] [PubMed]
11. Bhale, P.S.; Chavan, H.V.; Dongare, S.B.; Shringare, S.N.; Mule, Y.B.; Nagane, S.S.; Bandgar, B.P. Synthesis of extended conjugated indolyl chalcones as potent anti-breast cancer, anti-inflammatory and antioxidant agents. Bioorg. Med. Chem. Lett. 2017, 27, 1502–1507. [CrossRef] [PubMed]
12. Diao, P.C.; Li, Q.; Hu, M.J.; Ma, Y.F.; You, W.W.; Hong, K.H.; Zhao, P.L. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties. Eur. J. Med. Chem. 2017, 13, 110–118. [CrossRef] [PubMed]
13. Manuel-Manresa, P.; Korrodi-Gregório, L.; Hernando, E.; Villanueva, A.; Martínez-García, D.; Rodilla, A.M.; Ramos, R.; Fardilha, M.; Moya, J.; Quesada, R.; et al. Novel indole-based tambjamine-analogues induce apoptotic lung cancer cell death through p38 mitogen-activated protein kinase activation. Mol. Cancer. Ther. 2017, in press. [CrossRef] [PubMed]
14. Barbosa, V.A.; Baréa, P.; Mazia, R.S.; Ueda-Nakamura, T.; Costa, W.F.; Foglio, M.A.; Goes Ruiz, A.L.; Carvalho, J.E.; Vendramini-Costa, D.B.; Nakamura, C.V.; et al. Synthesis and evaluation of novel hybrids ?-carboline-4-thiazolidinones as potential antitumor and antiviral agents. Eur. J. Med. Chem. 2016, 124, 1093–1104. [CrossRef] [PubMed]
15. Kumar, V.P.; Renjitha, J.; Salfeena, C.F.; Ashitha, K.T.; Keri, R.S.; Varughese, S.; Sasidhar, B.S. Antibacterial and anti-tubercular evaluation of Dihydronaphthalenone-indole hybrid analogues. Chem. Biol. Drug. Des. 2017, in press. [CrossRef]
16. Patil, S.A.; Patil, S.A.; Patil, R. Medicinal applications of (benz)imidazole- and indole-based macrocycles. Chem. Biol. Drug. Des. 2017, 89, 639–649. [CrossRef] [PubMed]
17. Tan, M.C.; Wong, W.Y.; Ng, W.L.; Yeo, K.S.; Mohidin, T.B.; Lim, Y.Y.; Lafta, F.; Mohd Ali, H.; Ea, C.K. Identification of 5-Methoxy-2-(Diformylmethylidene)-3,3-Dimethylindole as an Anti-Influenza A Virus Agent. PLoS ONE 2017, 12, e0170352. [CrossRef] [PubMed]
18. Scuotto, M.; Abdelnabi, R.; Collarile, S.; Schiraldi, C.; Delang, L.; Massa, A.; Ferla, S.; Brancale, A.; Leyssen, P.; Neyts, J.; et al. Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication. Bioorg. Med. Chem. 2017, 25, 327–337. [CrossRef] [PubMed]
19. Che, Z.; Tian, Y.; Hu, Z.; Chen, Y.; Liu, S.; Chen, G. Synthesis and in vitro anti-HIV-1 activity of a series of N-arylsulfonyl-3-propionylindoles. Z. Naturforsch. C 2016, 71, 105–109. [CrossRef] [PubMed]
20. Silvestri, R.; De Martino, G.; La Regina, G.; Artico, M.; Massa, S.; Vargiu, L.; Mura, M.; Loi, A.G.; Marceddu, T.; La Colla, P. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: Synthesis and SAR studies. J. Med. Chem. 2003, 46, 2482–2493. [CrossRef] [PubMed]
21. Vera, G.; Lagos, C.F.; Almendras, S.; Hebel, D.; Flores, F.; Valle-Corvalán, G.; Pessoa-Mahana, C.D.; Mella-Raipán, J.; Montecinos, R.; Recabarren-Gajardo, G. Extended N-Arylsulfonylindoles as 5-HT6 Receptor Antagonists: Design, Synthesis & amp; Biological Evaluation. Molecules 2016, 21, 1070.
22. Fan, L.L.; Liu, W.Q.; Xu, H.; Yang, L.M.; Lv, M.; Zheng, Y.T. Anti human immunodeficiency virus-1 (HIV-1) agents 3. synthesis and in vitro anti-HIV-1 activity of some N-arylsulfonylindoles. Chem. Pharm. Bull. (Tokyo) 2009, 57, 797–800. [CrossRef] [PubMed]
23. Xu, H.; Wang, Y.Y. Antifungal agents. Part 5: Synthesis and antifungal activities of aminoguanidine derivatives of N-arylsulfonyl-3-acylindoles. Bioorg. Med. Chem. Lett. 2010, 20, 7274–7277. [CrossRef] [PubMed]
24. Song, M.X.; Deng, X.Q.; Li, Y.R.; Zheng, C.J.; Hong, L.; Piao, H.R. Synthesis And biological evaluation of (E)-1-(substituted)-3-phenylprop-2-en-1-ones bearing rhodanines as potent antimicrobial agents. J. Enzym. Inhib. Med. Chem. 2014, 29, 647–653. [CrossRef] [PubMed]
25. Song, M.X.; Zheng, C.J.; Deng, X.Q.; Wei, Z.Y.; Piao, H.R. The Synthesis and Anti-Bacterial Activities of N-carboxymethyl Rhodanines. Med. Chem. 2014, 4, 441–448.
26. Song, M.X.; Zheng, C.J.; Sun, L.P.; Wu, Y.; Hong, L.; Li, Y.J.; Liu, Y.; Wei, Z.Y.; Jin, M.J.; Piao, H.R. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA). Eur. J. Med. Chem. 2013, 60, 376–385. [CrossRef] [PubMed]
27. Song, M.X.; Zheng, C.J.; Deng, X.Q.; Wang, Q.; Hou, S.P.; Liu, T.T.; Xing, X.L.; Piao, H.R. Synthesis and bioactivity evaluation of rhodanine derivatives as potential anti-bacterial agents. Eur. J. Med. Chem. 2012, 54, 403–412. [CrossRef] [PubMed]
28. Zheng, C.J.; Song, M.X.; Sun, L.P.; Wu, Y.; Hong, L.; Piao, H.R. Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents. Bioorg. Med. Chem. Lett. 2012, 22, 7024–7028. [CrossRef] [PubMed]
29. Jin, X.; Zheng, C.J.; Song, M.X.; Wu, Y.; Sun, L.P.; Li, Y.J.; Yu, L.J.; Piao, H.R. Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone. Eur. J. Med. Chem. 2012, 56, 203–209. [CrossRef] [PubMed]
30. Chen, Z.H.; Zheng, C.J.; Sun, L.P.; Piao, H.R. Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity. Eur. J. Med. Chem. 2010, 45, 5739–5743. [CrossRef] [PubMed]
31. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A6; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2003.